CMI Model shows small drop in cohort life expectancy

18 April 2024

The Continuous Mortality Investigation (CMI) has released the latest annual update to the CMI Mortality Projections Model, CMI_2023.

CMI_2023 produces cohort life expectancies at age 65 that are about 5 weeks lower for males and about 2 weeks lower for females than in the previous version of the CMI model, CMI_2022. These changes are much smaller than between CMI_2021 and CMI_2022.

The CMI Model is used by UK pension schemes and insurance companies which need to make assumptions about future mortality rates. While mortality experience in 2020 and 2021 will affect actuarial calculations, mortality in both of those years was exceptional and is unlikely to be indicative of future mortality. For this reason, the CMI places no weight on the data for 2020 and 2021 in the core version of the model.

Standardised mortality rates in England & Wales have fallen each year since 2020. Mortality in 2023 was the third lowest on record and similar to the 2015-2019 average, but still above projections from versions of the CMI Model before the pandemic. Mortality in the first quarter of 2024 has also been relatively low, comparable to the start of 2019, which is still the lowest year on record.

Recent mortality is likely to be indicative of future mortality to some extent. Given that, and following consultation with users, the CMI has placed 15% weight on data for 2022 and 2023 when calibrating CMI_2023 while still placing no weight on data for 2020 and 2021.

As weights do not affect projections linearly, placing a 15% weight on data for 2022 and 2023 results in a projection that falls slightly closer to a projection that places full weight on these years than one that gives them no weight.

Cobus Daneel, Chair, CMI Mortality Projections Committee, said: “While recent mortality has been similar to the period immediately before the pandemic, the outlook for mortality remains uncertain. It is unclear whether there are just lingering short-term effects of the pandemic that will rapidly fade or whether the pandemic will have a fundamental impact on the longer-term mortality trend.

“The results of the consultation on CMI_2023 showed a sharp divide between insurer and reinsurer actuaries, who preferred a weight of 10% or less for 2022 and 2023 data, and pension consultants and other actuaries, who preferred higher weights for those years, typically 25% or more.

“Our chosen weight of 15% strikes a balance between these views and leads to a modest fall in life expectancies compared to CMI_2022. We encourage users our model to consider adjusting the model’s parameters to reflect their own portfolios and views on the impact of the pandemic.”

Detailed results

Chart A below shows standardised mortality rates (which allow for consistent comparisons of mortality over time) in the general population of England & Wales from 1983 to 2023.

There was a pronounced steady fall in mortality until 2011, but falls were more modest from 2011 to 2019. The increase in mortality from 2019 to 2020 was exceptional, with mortality in 2020 returning to levels of mortality last previously seen in 2008. Mortality fell between 2020 and 2023, returning to levels similar to 2016-2018 but higher than the relatively low mortality observed in 2019.

Chart A: Standardised mortality rates in England & Wales since 1983

Chart B below shows the progression of cohort life expectancy at age 65 in successive versions of the CMI Model. The figures for CMI_2023 are around 21 months lower than in the first version, CMI_2009.

Chart B: Cohort life expectancies as at 1 January 2024 at age 65 from CMI_2023 and earlier versions

For more information on the CMI Mortality Projections Model, CMI_2023, please see the FAQs.

The CMI Mortality Projections Committee produces “mortality monitors” – with weekly summaries of emerging mortality and more detailed analyses quarterly.

~ENDS~

Contact

Sonia Sequeira, Media Relations Manager, IFoA
Tel: 07525 592 198
Email: sonia.sequeira@actuaries.org.uk

Notes to editors

  1. CMI Mortality Projections Model CMI_2023 - Frequently asked questions
  2. Cohort life expectancy allows for assumed future changes in mortality rates. As future changes are unknown, it is a subjective measure. It is typically used by actuaries who need to use realistic assumptions about the lifespan of pension scheme members or insurance company policyholders. In contrast, period life expectancy only allows for changes in mortality rates to date and makes no allowance for future changes. It is an objective measure that is often reported by the Office for National Statistics.
  3. Because mortality rates are higher at older ages, changes in the age distribution of a population can lead to apparent changes in average mortality rates, even if mortality rates at each age do not change. A standardised mortality rate (SMR) can be thought of an average mortality rate for a group of lives, assuming that it has a standard age profile. This enables us to make a consistent comparison of mortality rates over time and between groups. We use the age profile of the 2013 European Standard Population for ages 20 to 100.
  4. The CMI Mortality Projections Model (the “CMI Model”) was introduced in 2009 to replace previous projections and has been updated on a broadly annual basis since then. It is based on mortality data for the population of England & Wales, published by the Office for National Statistics.
  5. The CMI Model is typically used by UK pension schemes and insurance companies which need to make assumptions about future mortality rates. The Model does not provide an assumption around long-term mortality improvements, requiring users to make their own assessment.
  6. Life expectancy for different groups, such as particular pension schemes and groups of policyholders, can vary considerably, and the CMI encourages users of the CMI Model to make appropriate assumptions for the purpose that it is being used for.

About the Continuous Mortality Investigation

Continuous Mortality Investigation Limited (‘the CMI’) is wholly owned by the Institute and Faculty of Actuaries but has an independent executive and management.

The CMI’s mission is to produce high-quality impartial analysis, standard tables and models of mortality and morbidity for long-term insurance products and pension scheme liabilities on behalf of subscribers and, in doing so, to further actuarial understanding.

About the Institute and Faculty of Actuaries

The Institute and Faculty of Actuaries (IFoA) is a royal chartered, not-for-profit, professional body.

Research undertaken by the IFoA is not commercial. As a learned society, research helps us to fulfil our royal charter requirements to further actuarial science and serve the public interest.

Actuaries provide commercial, financial and prudential advice on the management of a business’s assets and liabilities, especially where long term management and planning are critical to the success of any business venture. They also advise individuals, and advise on social and public interest issues.

Members of the IFoA have a statutory role in the supervision of pension funds and life insurance companies. They also have a statutory role to provide actuarial opinions for managing agents at Lloyd’s of London.

Members are governed by the Institute and Faculty of Actuaries. A rigorous examination system is supported by a programme of continuing professional development and a professional code of conduct supports high standards reflecting the significant role of actuaries in society.

The IFoA is available to provide independent expert comment to the media on a range of actuarial-related issues, including COVID-19 and its long term consequences, mortality, pensions, life and general insurance, health and care, finance and investment, climate change and sustainability, systems thinking, uncertainty and judgement, and risk management.